Literature DB >> 20650982

Surfactant protein B and RAGE increases in the plasma during cardiopulmonary bypass: a pilot study.

P Agostoni1, C Banfi, M Brioschi, D Magrì, S Sciomer, G Berna, C Brambillasca, G Marenzi, E Sisillo.   

Abstract

Surfactant derived protein B (SPB) and plasma receptor for advanced glycation end products (RAGE) have been proposed as markers of lung injury. The former is produced specifically by pneumocytes while RAGE production is present in several body tissues. Cardiopulmonary bypass (CPB) generates a transient lung injury. We measured SPB and RAGE in plasma before surgery and after CPB, as well as 24 h and 48 h later. We analysed plasma samples from 20 subjects scheduled for elective coronary artery bypass grafting. We performed a quantitative analysis of plasma levels of RAGE and SPB mature form (8 kDa) by ELISA and a semi-quantitative analysis of SPB immature form (~ 40 kDa) by Western blotting. Surgery procedures were uneventful. After CPB RAGE median (75th-25th interquartile difference) increased from 633 (539) pg·mL⁻¹ to 1,362 (557) pg·mL⁻¹ (p < 0.01), while mature SPB increased from 5,587 (3,089) ng·mL⁻¹ to 20,307 (19,873) ng·mL⁻¹ (p < 0.01). RAGE and mature SPB returned to normal values within 48 h. This behaviour was confirmed when RAGE and SPB were normalised for protein content. Parallel changes were observed for immature SPB. Plasma RAGE and SPBs are sensitive and rapid markers of lung distress.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20650982     DOI: 10.1183/09031936.00045910

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  13 in total

Review 1.  Shotgun MS proteomic analysis of bronchoalveolar lavage fluid in normal subjects.

Authors:  Elizabeth V Nguyen; Sina A Gharib; Lynn M Schnapp; David R Goodlett
Journal:  Proteomics Clin Appl       Date:  2014-10       Impact factor: 3.494

2.  Contribution of damage-associated molecular patterns to transfusion-related acute lung injury in cardiac surgery.

Authors:  Marcella C A Müller; Pieter R Tuinman; Alexander P Vlaar; Anita M Tuip; Kelly Maijoor; Achmed Achouiti; Cornelis Van t Veer; Margreeth B Vroom; Nicole P Juffermans
Journal:  Blood Transfus       Date:  2014-01-02       Impact factor: 3.443

3.  Plasma sRAGE enables prediction of acute lung injury after cardiac surgery in children.

Authors:  XiWang Liu; QiXing Chen; ShanShan Shi; Zhuo Shi; Ru Lin; LinHua Tan; JianGen Yu; Qiang Shu; XiangMing Fang
Journal:  Crit Care       Date:  2012-05-22       Impact factor: 9.097

Review 4.  Biomarkers of lung injury in cardiothoracic surgery.

Authors:  Gerwin Erik Engels; Willem van Oeveren
Journal:  Dis Markers       Date:  2015-03-17       Impact factor: 3.434

5.  Fetal and neonatal samples of a precursor surfactant protein B inversely related to gestational age.

Authors:  Christoph Czernik; Gerd Schmalisch; Christoph Bührer; Hans Proquitté
Journal:  BMC Pediatr       Date:  2013-10-10       Impact factor: 2.125

6.  Surfactant-derived proteins as markers of alveolar membrane damage in heart failure.

Authors:  Paola Gargiulo; Cristina Banfi; Stefania Ghilardi; Damiano Magrì; Marta Giovannardi; Alice Bonomi; Elisabetta Salvioni; Elisa Battaia; Pasquale Perrone Filardi; Elena Tremoli; Piergiuseppe Agostoni
Journal:  PLoS One       Date:  2014-12-16       Impact factor: 3.240

7.  The utility of lung epithelium specific biomarkers in cardiac surgery: a comparison of biomarker profiles in on- and off-pump coronary bypass surgery.

Authors:  Gerwin E Engels; Y John Gu; Willem van Oeveren; Gerhard Rakhorst; Massimo A Mariani; Michiel E Erasmus
Journal:  J Cardiothorac Surg       Date:  2013-01-09       Impact factor: 1.637

8.  Association between preoperative plasma sRAGE levels and recovery from cardiac surgery.

Authors:  Benedict C Creagh-Brown; Gregory J Quinlan; Lauren R Hector; Timothy W Evans; Anne Burke-Gaffney
Journal:  Mediators Inflamm       Date:  2013-09-05       Impact factor: 4.711

9.  Soluble isoform of the receptor for advanced glycation end products as a biomarker for postoperative respiratory failure after cardiac surgery.

Authors:  Tokujiro Uchida; Nagara Ohno; Miho Asahara; Yoshitsugu Yamada; Osamu Yamaguchi; Makoto Tomita; Koshi Makita
Journal:  PLoS One       Date:  2013-07-23       Impact factor: 3.240

10.  Soluble receptor for advanced glycation end products as an indicator of pulmonary vascular injury after cardiac surgery.

Authors:  Pieter R Tuinman; Alexander D Cornet; Maria T Kuipers; Alexander P Vlaar; Marcus J Schultz; Albertus Beishuizen; A B Johan Groeneveld; Nicole P Juffermans
Journal:  BMC Pulm Med       Date:  2013-12-16       Impact factor: 3.317

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.